findmyKOL
Clinical trialNCT04860154CompletedInterventional

Photodynamic Therapy for Cholangiocarcinoma

SponsorHepatopancreatobiliary Surgery Institute of Gansu ProvinceEnrollment86Cholangiocarcinoma Non-resectable
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Comparison of the bile duct patency with photodynamic therapy (PDT) and regular Endoscopic Retrograde Cholangiopancreatography(ERCP) stents in unresectable cholangiocarcinoma.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Southwest Hospital, Army Medical University

    Chongqing, Chongqing Municipality, China

  • the First Hospital of Lanzhou University

    Lanzhou, Gansu, China

  • the Second Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • the First Hospital of Jilin University

    Changchun, Jilin, China

  • General Hospital of Ningxia Medical University

    Yingchuan, Ningxia, China

  • the First Affiliated Hospital of Xi 'An Jiaotong University

    Xi'an, Shaanxi, China

  • Shandong Provincial Third Hospital

    Jinan, Shandong, China

  • Xinhua Hospital, Affiliated To Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China

  • General Hospital of Taiyuan Iron and Steel Corporation

    Taiyuan, Shanxi, China

  • the First Affiliated Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Hematoporphyrin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Apr 2021
Primary completion
19 Nov 2024
Completion
19 Nov 2024
Last update posted
20 Nov 2024
Registered enrollment
86
Registry id
NCT04860154
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.